Glucagon Like Peptide-1 Agonists Market Will Expand at 13.30% CAGR Up to 2025: QY Research, Inc.
Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
View full press release